Skip to content
MedsAcross

Medicine

Cyclophosphamide 25 mg capsule

Available on requestPrescription onlyUS FDAGeneric name

Cyclophosphamide 25 mg capsule is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Cyclophosphamide
Brand
Sold under the generic name
Strength
25 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules and 3 more
Manufacturers
Alembic PharmaceuticalsIndiaCiplaIndiaAmneal PharmaceuticalsHikma PharmaceuticalsOPKO Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L01AA01 Cyclophosphamide
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
16 September 2013
Identifiers
RxCUI 1437968, 1437969DailyMed set ID 9e699cf7-860e-4c03-9760-0c24d56df2de, d8057d1a-e8af-42ab-9da2-b545730b2655, 3d6e68b1-5120-4cbb-a9d2-fb09d1b74ea1 +3NDC 46708-618, 70301-2013, 62332-618 +3Application ANDA215892, ANDA218282, ANDA211608 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle46708-618-31Alembic PharmaceuticalsIndia23 November 2022
100 capsule in 1 bottle62332-618-31Alembic PharmaceuticalsIndia23 November 2022
100 capsule in 1 bottle69097-516-07CiplaIndia18 January 2019
100 capsule in 1 bottle69238-1561-1Amneal Pharmaceuticals3 November 2026
100 capsule in 1 bottle0054-0382-25Hikma Pharmaceuticals16 September 2013
100 capsule in 1 bottle70301-2013-1OPKO Pharmaceuticals16 September 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 16 November 1959Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Cyclophosphamide

Clinical summary

Cyclophosphamide is a prescription medicine indicated for treatment of malignant Diseases, among other approved uses. It is available as powder for injection, injection and capsules for intravenous and oral use. MedsAcross supplies Cyclophosphamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Cyclophosphamide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Cyclophosphamide 25 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.